NHS trial will test blood tests for earlier cancer referrals
The newly announced STRIDE-RCT study will assess tests in more than 20,000 NHS patients across at least 200 GP practices in England.
What the record says
A new NHS trial will examine whether blood tests can help GPs identify patients who need further investigation for cancer, the UK government announced November 4. STRIDE-RCT is planned to involve more than 20,000 patients across at least 200 GP practices in England. Participating patients aged 45 and older who visit with abdominal symptoms may be offered a chance to take part. The study will evaluate tests for signs of several cancers alongside GPs’ clinical judgment. The announcement says a positive result may help inform an urgent referral but is not itself a confirmed cancer diagnosis. The trial will receive up to £8.49 million in government funding through the Office for Life Sciences and NIHR. Results will be assessed before decisions about nationwide use.
Source details and supporting locations.
Practical next step
Read the government announcement for the study’s scope. Patients can discuss symptoms and available care with their GP.
Limits and what is not established
This is a trial announcement, not evidence that the tests improve survival or an announcement of nationwide screening. Participation and availability depend on the study.
Sources checked November 4, 2026. Later notices may change instructions or arrangements.
Original sources
UK Department of Health and Social Care: original information